Southern Research partners with international biotech firm
Southern Research has made its first licensing agreement in 10 years in an effort to develop a new anti-cancer drug.
The Birmingham nonprofit has signed a research and license contract with startup biotech firm Bionetix Inc. out of Suwon, South Korea. The two companies plan to develop a drug that affects a key genetic switch associated with suppression and regulation of the growth of certain types of cancer.
“ The collaborative effort with Bionetix will allow us to accelerate our exploration of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tyler Patchen Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Contracts | Genetics | Health Management | South Korea Health